m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0216)
| Name |
BHBA
|
||||
|---|---|---|---|---|---|
| Synonyms |
3-hydroxybutyric acid, 3-hydroxybutanoic acid, 300-85-6, Butanoic acid, 3-hydroxy-, DL-3-Hydroxybutyric Acid, 625-71-8, beta-Hydroxybutyric acid, 3 HBA, 3-Hydroxybuttersaeure, Butyric acid, 3-hydroxy-, DL-beta-Hydroxybutyric acid, beta-Hydroxybuttersaeure, 26063-00-3, beta-Hydroxy-n-butyric acid, poly(3-hydroxybutyric acid), 3-hydroxy-butanoic acid, .beta.-Hydroxybutyric acid, (1)-3-Hydroxybutyric acid, (+-)-3-Hydroxybutyric acid, beta-hydroxy-butyrate, D,l-3 hydroxybutyrate, beta-hydroxybutanoic acid, NSC 3806, NSC-3806, Hydroxybutyric acid, dl-, MFCD00004546, .beta.-Hydroxy-n-butyric acid, AI3-21675, (+/-)-3-Hydroxybutyric Acid, D(-)-beta-hydroxy butyric acid, CHEBI:20067, 3-hydroxybutyric acid, (+/-)-, TZP1275679, Butyric acid, 3-hydroxy- (8CI), 3-Hydroxybutanoic Acid + 3-(3-Hydroxybutyryloxy)butyric Acid (CAS:7565-79-9) (50:50 Mixture), SMR000112209, (+/-)-3-Hydroxybutyric Acid (Technical Grade), MFCD00137685, UNII-TZP1275679, EINECS 206-099-9, EINECS 210-908-0, 3-OH-butyric acid, BHBA, 3- hydroxybutyric acid, 3-hydroxy-butyric acid, DL-3-HydroxybutyricAcid, d,l-3-hydroxybutyric acid, bmse000161, bmse000905, SCHEMBL2731, (RS)-3-hydroxybutyric acid, (+/-)-beta-Hydroxybutyrate, MLS001332397, MLS001332398, 3-Hydroxybutyric acid, 95%, DL-.beta.-Hydroxybutyric acid, (+/-)-3-Hydroxybutanoic acid, CHEMBL1162496, .BETA.HYDROXYBUTYRIC ACID, DTXSID60859511, NSC3806, (.+/-.)-3-Hydroxybutyric acid, 3-Hydroxybutyric acid, tech grade, HMS2270C20, HMS3369F13, BBL027467, HB4640, LMFA01050005, s1031, STL377875, AKOS009156821, AB88579, AC-5701, FH30882, SB44475, Butanoic acid, 3-hydroxy-, (+/-)-, .BETA.-HYDROXYBUTYRIC ACID [MI], Butanoic acid, 3-hydroxy-, (A+/-)-, BETA-HYDROXYBUTYRIC ACID [WHO-DD], FP179872, SY074781, SY076545, SY114480, VS-08544, HY-113378, CS-0062335, H0228, NS00014717, Poly(3-hydroxybutyric acid), MW~500,000, D84191, EN300-147463, Poly[(R)-3-hydroxybutyrate], Mn ~500,000, Q223092, BRD-A41387824-001-06-0, (+/-)-3-Hydroxybutanoic acid;DL--Hydroxybutyric acid, 869DD3C9-3114-4BE2-B4A6-6F1787476E95
Click to Show/Hide
|
||||
| Structure |
 |
||||
|
3D MOL
|
|||||
| Formula |
C4H8O3
|
||||
| InChI |
InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)
|
||||
| InChIKey |
WHBMMWSBFZVSSR-UHFFFAOYSA-N
|
||||
| PubChem CID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 3 item(s) under this drug | ||
| Crosstalk ID: M6ACROT03166 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | . | |
| Regulated Target | Histone H3 lysine 9 acetylation (H3K9ac) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver injury | |
| Crosstalk ID: M6ACROT03167 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | . | |
| Regulated Target | Histone H3 lysine 27 acetylation (H3K27ac) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver injury | |
| Crosstalk ID: M6ACROT03168 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | . | |
| Regulated Target | Histone H3 lysine 36 trimethylation (H3K36me3) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver injury | |